[Rituximab therapy for refractory thrombocytopenia in patients with antiphospholipid antibodies]

An Pediatr (Barc). 2017 Jul;87(1):51-53. doi: 10.1016/j.anpedi.2016.09.007. Epub 2016 Oct 21.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antiphospholipid Syndrome / complications
  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Male
  • Rituximab / therapeutic use*
  • Thrombocytopenia / drug therapy*
  • Thrombocytopenia / etiology

Substances

  • Immunologic Factors
  • Rituximab